Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients.

Meenu Bajpai Ashish Maheshwari Suresh Kumar Karan Chhabra Pratibha Kale Ashad Narayanan Amita Gupta Ekta Gupta Nirupama Trehanpati Reshu Agarwal Kamini Gupta Ankit Bhardwaj Mojahidul Islam Ravinder Singh Pushpa Yadav Guresh Kumar Shiv Kumar Sarin

Published in: Anais da Academia Brasileira de Ciencias (2022)

The proportion of patients free of ventilation at day seven were 78.5% in COPLA group, and 93.3 % in control group were not significant (p= 0.258). However, improved respiratory rate, O2 saturation, SOFA score, and Ct value were observed in the COPLA group. No serious adverse events were noticed by plasma transfusion in both groups.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
sars cov
computed tomography
magnetic resonance
early onset
sickle cell disease
mechanical ventilation
intensive care unit
positron emission tomography
respiratory failure